Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26673198 | 1.00 | HCAR2 (0.50) | HCAR2L3MBTL1KMT2AMEN1TSHR | |
| SCHEMBL26673292 | 0.81 | HCAR2 (0.50) | HCAR2L3MBTL1KMT2AMEN1TSHR | |
| SCHEMBL30640411 | 0.81 | HCAR2 (0.50) | HCAR2L3MBTL1KMT2AMEN1TSHR | |
| SCHEMBL31585402 | 0.81 | KDM4E (0.53) | HCAR2L3MBTL1TSHRMAPTHTT | |
| SCHEMBL30640375 | 0.80 | HCAR2 (0.61) | HCAR2KMT2AMEN1SMYD3ALDH1A1 | |
| SCHEMBL26673315 | 0.80 | HCAR2 (0.61) | HCAR2KMT2AMEN1SMYD3ALDH1A1 | |
| SCHEMBL8412985 | 0.77 | ALDH1A1 (0.44) | L3MBTL1KMT2AMAPTALDH1A1MAPK1 | |
| SCHEMBL1436200 | 0.76 | ATM (0.65) | HCAR2SMYD3CYP11B1CYP11B2ATM | |
| SCHEMBL14691488 | 0.75 | HCAR2 (0.54) | HCAR2KMT2ASMYD3ATMMAPT | |
| SCHEMBL9263357 | 0.75 | KMT2A (0.60) | L3MBTL1KMT2AMEN1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4526300-A1 | RIPK1 INHIBITORS AND METHODS OF USE | Merck Sharp & Dohme LLC (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023225041-A1 | RIPK1 INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2023-11-23 | — | — | WO | disclosed |